°øÁö : µµÄìÁõ±Ç°Å·¡¼Ò JASDAQ ½ºÅÄ´Ùµå ½ÃÀå ½Å±Ô »óÀå °ü·Ã ¾È³»

Global Information
ȸ»ç¼Ò°³ | ¹®ÀÇ | ºñ±³¸®½ºÆ®
EnglishJapaness Traditional Chinese Simplified Chinese
Ȩ > ±Û·Î¹ú ÆÄÆ®³Ê > La Merie Publishing
Ä«Å×°í¸®·Î ã±â
Áö¿ªº°

La Merie Publishing

½ºÆäÀÎ ¹Ù¸£¼¿·Î³ª¿¡ º»»ç¸¦ µÐ La Merie´Â ¹ÙÀÌ¿À Å×Å©³î·¯Áö ¹× Á¦¾à »ê¾÷¿¡ ´ëÇÑ ¸®¼­Ä¡¸¦ Àü¹®À¸·Î Çϰí ÀÖ½À´Ï´Ù.

»ó¼¼ ºÐ·ù
Á¦¸ñ °Ë»ö
1 - 17 ¸®ºä (Àüü£º 17 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
302689
¹ßÇàÁ¤º¸
¿¬°£±¸µ¶
ÆäÀÌÁö Á¤º¸
 
°¡°Ý
EUR 6,000 -> £Ü 8,073,000
Report Package - 4 for 2: "Drug the Undruggable" Technologies
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
936691
¹ßÇà
2020³â 05¿ù
ÆäÀÌÁö Á¤º¸
4 Reports
°¡°Ý
EUR 4,125 -> £Ü 5,550,000
¿­¶÷¼­ºñ½º
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners from an Industry Perspective
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
936351
¹ßÇà
2020³â 05¿ù
ÆäÀÌÁö Á¤º¸
195 Pages
°¡°Ý
EUR 2,050 -> £Ü 2,758,000
¿­¶÷¼­ºñ½º
RNA-Targeted Small Molecules 2019: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners from an Industry Perspective
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
911032
¹ßÇà
2019³â 09¿ù
ÆäÀÌÁö Á¤º¸
223 Pages
°¡°Ý
EUR 2,050 -> £Ü 2,758,000
¿­¶÷¼­ºñ½º
2 Reports Bundle - Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases plus T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
890416
¹ßÇà
2019³â 06¿ù
ÆäÀÌÁö Á¤º¸
 
°¡°Ý
EUR 2,500 -> £Ü 3,363,000
¿­¶÷¼­ºñ½º
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
890224
¹ßÇà
2019³â 06¿ù
ÆäÀÌÁö Á¤º¸
125 Pages
°¡°Ý
EUR 800 -> £Ü 1,076,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
868394
¹ßÇà
2019³â 06¿ù
ÆäÀÌÁö Á¤º¸
463 Pages
°¡°Ý
EUR 2,350 -> £Ü 3,161,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
408112
¹ßÇà
2018³â 07¿ù
ÆäÀÌÁö Á¤º¸
455 Pages
°¡°Ý
EUR 1,440 -> £Ü 1,937,000
¿­¶÷¼­ºñ½º
6 Reports Bundle: Immunotherapeutics Targeting MAGE-A, NY-ESO-1, hTERT, WT1, PRAME and Survivin
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
651129
¹ßÇà
2018³â 06¿ù
ÆäÀÌÁö Á¤º¸
 
°¡°Ý
EUR 810 -> £Ü 1,089,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
651128
¹ßÇà
2018³â 05¿ù
ÆäÀÌÁö Á¤º¸
 
°¡°Ý
EUR 2,967 -> £Ü 3,992,000
¿­¶÷¼­ºñ½º
TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
642119
¹ßÇà
2018³â 05¿ù
ÆäÀÌÁö Á¤º¸
294 Pages
°¡°Ý
EUR 2,150 -> £Ü 2,892,000
¿­¶÷¼­ºñ½º
Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
600758
¹ßÇà
2018³â 01¿ù
ÆäÀÌÁö Á¤º¸
251 Pages
°¡°Ý
EUR 2,300 -> £Ü 3,094,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
358307
¹ßÇà
2017³â 11¿ù
ÆäÀÌÁö Á¤º¸
58 Pages
°¡°Ý
EUR 450 -> £Ü 605,000
¿­¶÷¼­ºñ½º
2 Reports Bundle: Immunotherapy with Oncolytic Viruses and mRNA Vaccines & Therapeutics
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
579795
¹ßÇà
2017³â 10¿ù
ÆäÀÌÁö Á¤º¸
 
°¡°Ý
EUR 3,080 -> £Ü 4,144,000
¿­¶÷¼­ºñ½º
mRNA Vaccines & Therapeutics 2017: An Industry Analysis of Technologies, Pipelines, Stakeholders and Deals
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
518829
¹ßÇà
2017³â 06¿ù
ÆäÀÌÁö Á¤º¸
260 Pages
°¡°Ý
EUR 2,250 -> £Ü 3,027,000
¿­¶÷¼­ºñ½º
The Oncolytic Virus Landscape 2017: An Analysis of Pipeline, Stakeholders, Deals, Industry Trends & Opportunities
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
425869
¹ßÇà
2017³â 01¿ù
ÆäÀÌÁö Á¤º¸
225 Pages
°¡°Ý
EUR 2,150 -> £Ü 2,892,000
¿­¶÷¼­ºñ½º
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update
¸®¼­Ä¡»ç
La Merie Publishing
»óǰÄÚµå
327820
¹ßÇà
2016³â 05¿ù
ÆäÀÌÁö Á¤º¸
462 Pages
°¡°Ý
EUR 1,300 -> £Ü 1,749,000
¿­¶÷¼­ºñ½º

»ó±â ÀÚ·á ÀÌ¿ÜÀÇ La Merie Publishing ÀÚ·áµµ ÁÖ¹® °¡´ÉÇÏ´Ï ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦